Institutional Biosafety Committee (IBC) | EHS https://www.ehs.washington.edu/biological/institutional-biosafety-comm...

(/)
About COVID-19 Report Spills Training Waste

POPULAR SERVICES BIOLOGICAL CHEMICAL ENVIRONMENTAL FIRE & LIFE RADIATION RESEARCH & LAB

WORKPLACE

Biological

(/)

Biological (/biological-safety) Institutional Biosafety Committee (IBC)

B
Biioollooggiiccaall

Biohazardous Waste (/biological/biohazardous-waste)

Biological Research Approval (/biological/biological-research-approval)

Biological Research Safety (/biological/biological-research-safety)

Biological Safety Cabinets (/biological/biological-safety-cabinets)

Bloodborne Pathogens (BBP) Program (/biological/bloodborne-pathogens-bbp-program)

Clinical Trials (/biological/clinical-trials)

COVID-19 Research Biosafety (/biological/covid-19-research-biosafety)

IIn
nssttiittu
uttiioon
naall B
Biioossaaffeettyy C
Coom
mmmiitttteeee ((IIB
BCC))

Select Agent Program (/biological/select-agent-program)

Sharps and Lab Glass Waste (/biological/sharps-and-lab-glass-waste)

1 of 5 5/10/2023, 5:53 AM
Institutional Biosafety Committee (IBC) | EHS https://www.ehs.washington.edu/biological/institutional-biosafety-comm...

Viral Vectors for Gene Transfer (/biological/viral-vectors-gene-transfer)

Institutional Biosafety Committee (IBC)

The Institutional Biosafety Committee (IBC) reviews, approves and oversees research involving the use of
recombinant or synthetic DNA/RNA and other biohazards.

All work involving biohazards, including recombinant or synthetic DNA/RNA, is reviewed by the Institutional
Biosafety Committee (IBC) and EH&S. The National Institutes of Health (NIH) require us to have an IBC. The
committee approves procedures for procurement, use, storage, transportation and disposal of biohazardous
material.

IBC meetings are open to the public. The agenda (https://www.ehs.washington.edu/system/�les/resources

/IBC-agenda.pdf) is posted at least 24 hours prior to the meeting. Meeting minutes are posted on this page as
they become available.

IBC Policies
Viral Vectors
Viral Vectors for Gene Transfer (/biological/viral-vectors-gene-transfer) lists the most commonly used viral
vectors and options for replication competent virus (RCV) testing. Some vectors can be used at a lower
biosafety level if tested negative for RCV. Contact EH&S �rst to con�rm that RCV testing is an option for your
proposed work.

The IBC has established a working de�nition of third generation lentiviral vectors. If vectors meet the
de�nition of third generation, biocontainment may be lowered for use with oncogenic inserts. Refer to Third
Generation Lentiviral Vectors (http://www.ehs.washington.edu/system/�les/resources/third-gen-lenti.pdf) for
more information.

Vaccinia Virus Research Safety Policy

EH&S and the IBC have developed a policy for those working with or entering locations where vaccinia virus is
used. Review the Vaccinia Virus Research Safety Policy (http://www.ehs.washington.edu/system/�les
/resources/vaccinia-policy.pdf) for more information.

What you need to know

IBC monthly meetings are held on the third Wednesday of each month. Meetings are open to the public and
take place from 10:00 a.m. to 12:00 noon. The meeting is held virtually with a location for in-person
attendance. Refer to the posted IBC agenda (https://www.ehs.washington.edu/system/�les/resources/IBC-

2 of 5 5/10/2023, 5:53 AM
Institutional Biosafety Committee (IBC) | EHS https://www.ehs.washington.edu/biological/institutional-biosafety-comm...

agenda.pdf) for meeting attendance information.

The IBC reviews applications for Biological Use Authorizations (BUAs) during meetings. You must submit a
complete and accurate BUA application (http://www.ehs.washington.edu/system/�les/resources/bua-
application.docx) or a Request for Change to BUA application (http://www.ehs.washington.edu/system/�les
/resources/bua-change.docx) by 5:00 p.m. four weeks prior to the meeting at which you’d like your project to
be reviewed. Clinical trial BUA applications (http://www.ehs.washington.edu/resource/clinical-trial-biological-
use-authorization-bua-application-604) may require up to six weeks for review. Refer to the BUA submission
deadlines (https://www.ehs.washington.edu/system/�les/resources/BUA-submission-dates.pdf).

Submit a complete BUA application (http://www.ehs.washington.edu/system/�les/resources/bua-

application.docx) (Word) or Change to BUA application (http://www.ehs.washington.edu/system/�les
/resources/bua-change.docx) (Word) to ehsbio@uw.edu (mailto:ehsbio@uw.edu).

The IBC will review BUA applications and clinical trial BUA applications according to a pre-determined process
(http://www.ehs.washington.edu/system/�les/resources/IBC-project-review.pdf).

Visit the Biological Research Approval page (http://www.ehs.washington.edu/biological/biological-research-

approval) for more information.

What you can do to stay safe

• Be sure any research with biohazards is approved by the IBC. Submit a BUA application for any work
involving biohazards, including recombinant or synthetic DNA/RNA.
• Follow all of the biosafety containment practices and procedures and additional guidance as speci�ed in
your BUA letter.
• Get involved! Attend a meeting to see how research involving biohazards is reviewed.

Meeting Minutes
2023 IBC Meeting Minutes

2022 IBC Meeting Minutes

2021 IBC Meeting Minutes

2020 IBC Meeting Minutes

2019 IBC Meeting Minutes

2018 IBC Meeting Minutes

3 of 5 5/10/2023, 5:53 AM
Institutional Biosafety Committee (IBC) | EHS https://www.ehs.washington.edu/biological/institutional-biosafety-comm...

2017 IBC Meeting Minutes

2016 IBC Meeting Minutes

2015 IBC Meeting Minutes

2014 IBC Meeting Minutes

Prior to 2014

More information
Trainings

Regulation and policy

CONTACT

Biological Safety Contact

(206) 221-7770
ehsbio@uw.edu (mailto:ehsbio@uw.edu)

REFERENCE FILES

NIH Investigator Responsibilities (https://www.ehs.washington.edu/system/�les/resources/NIH-investigator-

responsibilities.pdf)
1.06MB (.pdf)

BUA Application Submission Deadlines (https://www.ehs.washington.edu/system/�les/resources/BUA-

submission-dates.pdf)
85.18KB (.pdf)

IBC Meeting Agenda (https://www.ehs.washington.edu/system/�les/resources/IBC-agenda.pdf)

214.93KB (.pdf)

IBC Project Review Flowchart (https://www.ehs.washington.edu/system/�les/resources/IBC-project-

review.pdf)
278.34KB (.pdf)

Biological Use Authorization (BUA) application (https://www.ehs.washington.edu/system/�les/resources/bua-

application.docx)

4 of 5 5/10/2023, 5:53 AM
Institutional Biosafety Committee (IBC) | EHS https://www.ehs.washington.edu/biological/institutional-biosafety-comm...

367.81KB (.docx)

Clinical Trial Biological Use Authorization (BUA) application (https://www.ehs.washington.edu/system/�les

/resources/clinicaltrial.docx)
303.15KB (.docx)

Institutional Biosafety Committee (IBC) Charter (https://www.ehs.washington.edu/system/�les/resources/ibc-

charter.pdf)
561.55KB (.pdf)

REFERENCE LINKS

COVID-19 Research Biosafety Guidance (https://www.ehs.washington.edu/biological/covid-19-research-

biosafety-guidance)
BUA Application FAQs (https://www.ehs.washington.edu/biological-use-authorization-bua-application-faqs)

(http://www.washington.edu/boundless/)

Accessibility / Contact Us / Campus Safety / Safety Training / Privacy / Terms / My Contents /

EHS Login

© 20 UW Environmental Health & Safety Department | 201 Hall Health Center, Box 354400, Seattle, WA | Tel: 206.543.7262 | Fax:
206.543.3351 | ehsdept@uw.edu (mailto:ehsdept@uw.edu)

5 of 5 5/10/2023, 5:53 AM